SCHEMBL7956767

SCHEMBL7956767

Cc1ccc(-c2noc(-c3ccccc3OCCN(C)C)n2)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.51
NPC1 O15118 7/20 0.51
S1PR1 P21453 4/20 0.51
S1PR3 Q99500 2/20 0.51
HSD17B10 Q99714 6/20 0.49
ALDH1A1 P00352 6/20 0.49
RAB9A P51151 6/20 0.49
TP53 P04637 5/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
HPGD P15428 3/20 0.49
TTR P02766 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
HTR7 P34969 3/20 0.49
RXFP1 Q9HBX9 1/20 0.46
KDM4E B2RXH2 5/20 0.45
MAPT P10636 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957088 0.90 NPC1 (0.49) SMN1; SMN2NPC1S1PR1HSD17B10ALDH1A1
SCHEMBL7958390 0.87 TTR (0.55) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
SCHEMBL7958616 0.87 NPC1 (0.67) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
SCHEMBL7954953 0.87 HSD17B10 (0.62) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
Irampanel SCHEMBL678128 0.86 HTR7 (0.63) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
SCHEMBL7958824 0.86 SMN1; SMN2 (0.51) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
SCHEMBL7955292 0.85 TTR (0.55) SMN1; SMN2NPC1S1PR1HSD17B10ALDH1A1
Irampanel SCHEMBL6879876 0.85 HTR7 (0.62) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A
SCHEMBL7960663 0.85 SMN1; SMN2 (0.52) SMN1; SMN2NPC1S1PR1HSD17B10ALDH1A1
SCHEMBL7954897 0.84 HTR7 (0.56) SMN1; SMN2NPC1HSD17B10ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277872-B1 ANTIISCHEMIC AGENTS; BRAIN DISORDERS BOEHRINGER INGELHEIM KG (DE) 2001-08-21 US disclosed